ACAD FY 2025 Earnings — ACADIA Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

ACADACADIA Pharmaceuticals Inc.

$4B

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1.1B+11.9% YoY

Gross Profit

$983M91.7% margin

Operating Income

$105M9.8% margin

Net Income

$391M36.5% margin

EPS (Diluted)

$2.29

Cash Flow

Operating Cash Flow

$110M

Free Cash Flow

$105M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$1.6B

Total Liabilities

$337M

Stockholders' Equity

$1.2B

Cash & Equivalents

$820M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.1B	$958M	+11.9%
Gross Profit	$983M	$876M	+12.2%
Operating Income	$105M	$231M	-54.6%
Net Income	$391M	$226M	+72.7%